Psychotropic Medication Utilization Review (PMUR) Process for STAR Health Members

Similar documents
INFORMED CONSENT FOR PSYCHOTROPIC MEDICATION

Psychotropic Medication

Antidepressants for treatment of depression.

Curbing the High Rates of Psychotropic Medication Prescriptions among Children and Youth in Foster Care

New Jersey Department of Children and Families Policy Manual. Date: Chapter: A Health Services Subchapter: 1 Health Services

ADMINISTRATIVE POLICY AND PROCEDURE

PSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE

Non-Executive Member Disciplinary Review Process

Driving and Epilepsy. When can you not drive? 1. Within 6 months of your last epileptic seizure.

Monitoring Psychotropic Use Among Foster Children EMPAA

MEDICATION USE IN ADULTS WITH ID/DD LIVING IN COMMUNITY HOMES AND STATE EFFORTS TO REDUCE OVERUSE

Z E N I T H M E D I C A L P R O V I D E R N E T W O R K P O L I C Y Title: Provider Appeal of Network Exclusion Policy

What if someone complains about me? A guide to the complaint process

Termination: Ending the Therapeutic Relationship-Avoiding Abandonment

Medicaid Denied My Request for Services, Now What?

FOOTHILLS GATEWAY, INC. SummitStone Health Partners

1. A statement indicating that the physician has reviewed all medical information concerning the child which has been provided.

Facilitating Cross-System Data Sharing for Psychotropic Medication Oversight and Monitoring

Patient Reimbursement Guide. Brainsway Deep Transcranial Magnetic Stimulation (TMS) Treatment. Obtain Coverage - the Right Way

Guidelines for the Utilization of Psychotropic Medications for Children in Foster Care. Illinois Department of Children and Family Services

Medical gap arrangements - practitioner application

OUTPATIENT SERVICES PSYCHOLOGICAL SERVICES CONTRACT

Exhibit 2 RFQ Engagement Letter

Pediatric Behavioral Health Medication Initiative Prior Authorization (PA) Request Form

Electroconvulsive Treatment (ECT)

Child and Adolescent Psychiatry Trends. ADAMHS Board - 28 Oct 2014

Content Part 2 Users manual... 4

DIVISION CIRCULAR #21 (N/A) DEPARTMENT OF HUMAN SERVICES DIVISION OF DEVELOPMENTAL DISABILITIES

Unparalleled access to world-renowned cancer experts

4. The time limit, not less than thirty (30) calendar days, for requesting a Hearing in writing.

Trial Competency Restoration; The Thief of Justice?

65G Documentation and Notification.

Prepublication Requirements

NOTICE OF RIGHTS OF STUDENTS AND PARENTS UNDER SECTION 504

Due Process Hearing Request Information Sheet and Model Form

How to guide to the Control Self Assessment (CSA) tool and process

PROTECTING THE SPORT: GUIDE TO FEDERATION RULE ENFORCEMENT AND HEARING PROCESS

Introducing ValueOptions Clinical Care Alerts

Changes to the Mental Health Act Webinar for General Practitioners. Presenter: Dr Nathan Gibson Chief Psychiatrist

Appendix 11 Roles and Responsibilities October, 2013 Page 1 of 5

Section 32: BIMM Institute Student Disciplinary Procedure

What is Quitline Iowa?

The Pediatric Behavioral Health Medication Initiative September 2016

State of Connecticut Department of Education Division of Teaching and Learning Programs and Services Bureau of Special Education

Effective Date: May 19, Revised Date: August 18, Policy Number: MED Policy 313. Pain Management Long Term Opioid Use

Purpose: Policy: The Fair Hearing Plan is not applicable to mid-level providers. Grounds for a Hearing

Issue Alert

You Can Impact HEDIS Scores. Peer-to-Peer Review

Ministry of Children and Youth Services. Independent Clinical Review Process for the Ontario Autism Program. Guidelines

Psychotropic Medication. Including Role of Gradual Dose Reductions

Fitness to Stand Trial

Presentation Preparation

The New Mental Health Act A Guide to Named Persons

Inpatient Psychiatric Services for Under Age 21 Manual. Acute Inpatient Mental Health (Child/Adolescent)

TALKING TO PATIENTS AND FAMILIES ABOUT MEDICATIONS: IMPROVING QUALITY OF CARE AND REDUCING PROFESSIONAL LIABILITY RISK WHEN PRESCRIBING FOR CHILDREN

Policies, Procedures and Guidelines

A BETTER WAY FOR TOUGH KIDS:

Deciding whether a person has the capacity to make a decision the Mental Capacity Act 2005

NFA Arbitrators. Chairperson s Handbook

Talking with your doctors about palliative care Dr. Mary Anne Huggins and Barbara Pidcock

Recommendations for Components of Emergency Department Discharge Protocols

IDEA Early Intervention Due Process Complaints and Hearing Requests Part C Procedures

2012 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members

MISSION VISION OVERARCHING GOAL. An Overview of Behavioral Health Services. Clients thriving in their natural environments

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

PSYCHOLOGIST-PATIENT SERVICES

COMPLAINTS POLICY AND PROCEDURE

Creating a reminder for GSK vaccines in Allscripts Professional EHR

HOW TO APPLY FOR SOCIAL SECURITY DISABILITY BENEFITS IF YOU HAVE CHRONIC FATIGUE SYNDROME (CFS/CFIDS) MYALGIC ENCEPHALOPATHY (ME) and FIBROMYALGIA

DIRECTIONS FOR USING THE MENTAL HEALTH ADVANCE DIRECTIVE POWER OF ATTORNEY FORM

Judicial & Ethics Policy

Guideline for Concussion/Mild Traumatic Brain Injury and Persistent Symptoms. Patient Version

Graduate Student Academic Grievance Hearing Procedures. For the College of Education

1. Procedure for Academic Misconduct Committees, virtual panels and formal hearings

HEALTHWEST. Practice Guideline. No Prepared By: Effective: August 23, 1999 Revised: November 13, 2018

The Clean Environment Commission. Public Participation in the Environmental Review Process

THE WETC PSYCHOLOGY NEWSLETTER

Psychological Services Policy

Hydro One Networks Inc. 483 Bay Street, Toronto, Ontario M5G 2P5. July 7, Attention: Consultation Secretariat

Oncology Solutions Provider Training Program. Horizon NJ Health

Outpatient use of Atypical Antipsychotic Agents in the Pediatric Population Years

Selecting the right patient for medication reviews

Excise and Licenses Hearing Changes and Updates. Public Informational Meeting September 17, 2018

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

Special Education Informal Dispute Resolution Processes

Whistleblowing to Ofsted about local authority safeguarding services

Special Education Fact Sheet. Special Education Impartial Hearings in New York City

Research Protocol for REAP Bipolar Disorder (REAP-BD)

Professional Development: proposals for assuring the continuing fitness to practise of osteopaths. draft Peer Discussion Review Guidelines

MENTAL HEALTH. Power of Attorney

Ethics for the Expert Witness

ODP Deaf Services Overview Lesson 2 (PD) (music playing) Course Number

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Evaluation of a Medicaid Psychotropic Drug Management Program in Utah

Integrating INTERACT into Interim Pharmacist Reviews

The Components of an Objective IME

EHR Developer Code of Conduct Frequently Asked Questions

ASTHMA CARE FOR CHILDREN BASKET OF CARE SUBCOMMITTEE Report to: Minnesota Department of Health. June 22, 2009

APPENDIX B TAP 31 RESOLUTION PROCESS

Autism Advisor Program NSW

Transcription:

Psychotropic Medication Utilization Review (PMUR) Process for STAR Health Members FAQ and Stakeholder Manual Cenpatico/SHPN Updated March 26, 2015 201205_SHP_CBH_PMURFAQ - 1 -

The STAR Health Medication Monitoring Program Q: What indicators does Cenpatico/SHPN use to screen foster children in a PMUR? A: Children who have received treatment with a psychotropic medication(s) for 60 days or more that falls into the following categories: All children under the age of 4 years Any child whose medication regimen appears to have class polypharmacy as defined by: 2 or more concomitant stimulant medications 2 or more concomitant alpha agonists 2 or more concomitant antidepressants 2 or more concomitant antipsychotics 3 or more concomitant mood stabilizers Any child with 4 or more psychotropic medications (polypharmacy) Q: Where can I find the DFPS Psychotropic Medication Utilization Parameters? A: You can find them at the following link: http://www.dfps.state.tx.us/documents/child_protection/pdf/txfostercarepara meters-september2013.pdf Q: What are ways PMURs can be triggered? A: Health Screening SHPN/Cenpatico Service Managers do comprehensive screens on foster children and identify medication regimens which appear to be outside the DFPS Psychotropic Utilization Parameters Automated Pharmacy Claims Data Cenpatico has collaborated with HHSC to develop an automated screening program using pharmacy claims information. This screening is run monthly to identify foster children who have medication regimens which may fall outside the DFPS Psychotropic Medication Utilization Parameters - 2 -

External Request CPS Nurse Consultants, other CPS staff, CASAs, children s caregivers, attorneys, residential child care providers and other interested parties can request a medication review Court Request Judges having jurisdiction over CPS cases can request a PMUR to answer questions about a foster child s medication regimen Requests for PMURs Q: How do I request a PMUR for a foster child? A: Requests for PMUR can be directed to a Cenpatico Service Manager based on the foster child s placement region DFPS Regions Cenpatico Contact 3, 4, 7, 8 Michelle Perez-Vega, LCSW Behavioral Health Service Manager Cenpatico 1-866-534-5946 x 42709 DFPS Regions Cenpatico Contact 5, 6, 11 Aaron Sanborn, M.Ed., LPC-S Behavioral Health Service Manager Cenpatico 1-866-534-5946 x 42652 DFPS Regions Cenpatico Contact 1, 2, 9, 10 Bill Mallory, MA, LPC Behavioral Health Service Manager Cenpatico 1-866-534-5946 x 42105-3 -

Q: Will all requests result in a formal PMUR report? A: No. There are many instances where Cenpatico may be able to answer questions about medication usage and the DFPS Psychotropic Medication Utilization Parameters without the need for formal PMUR. In addition, the Cenpatico Service Manger will direct the requestor to the prescriber under certain circumstances. These include: 1. If the CPS staff, medical consenter, caregiver or other individual has questions about why a specific medication was prescribed by the physician. 2. If the medication regimen and dosages of medications prescribed are clearly within the DFPS Psychotropic Medication Utilization Parameters. 3. If the CPS staff, medical consenter, caregiver or other individual has questions about medication side effects, wants to stop a particular medication, or does not think the medication is needed. 4. If there are questions about giving consent for new medications or changes in medication doses recommended by the child s treating physician. 5. Requests made because the medication does not appear in the DFPS Psychotropic Medication Utilization Parameters for Foster Children (2013). 6. Concerns about giving consent for new medications or changes in medication doses while foster children are in treatment at a psychiatric hospital. Q: Why won t all the requests result in a formal PMUR report? A: Cenpatico encourages CPS staff, medical consenters and caregivers to contact the treating physician directly with questions about why a specific medication or dosage was prescribed. Only the treating physician can answer why the specific medication was prescribed based on the foster child s problems and symptoms. More importantly, the PMUR process can take 2-3 weeks to complete, and waiting for the formal PMUR report can delay needed treatment, or change in medications. The treating physician should be made aware of any concerns about side effects immediately to take any necessary action. - 4 -

Q: What other resources do CPS staff members have when they have questions about medications? A: The CPS Regional Nurse Consultants can also assist with medication questions, and consent issues. The CPS Nurse Consultants can make referrals to Cenpatico to initiate a PMUR investigation, if needed. Q: If I m a CPS Caseworker, and I m going to court can I get a PMUR report for court? A: Cenpatico will attempt to complete PMURs requested by caseworkers for status, permanency and placement hearings. If the medication review is court ordered, the Cenpatico Service Manager will ask for a copy of the court documents to ensure the court s concerns are addressed in the report, and will submit to the court a copy of the final PMUR report. Upon request, the Cenpatico Service Manager has 3 business days to gather needed information to submit the PMUR request for review. Extension to the 3 day deadline may be granted if physician notes are not obtained within this timeframe. The Cenpatico Medical Director will review the information and forward to the consultant child psychiatrist. If there is not enough information, the process could be delayed. The consultant has 10 business days to attempt peer-peer contact with the treating physician, and complete the PMUR report. Please note that Cenpatico will make every effort to expedite a PMUR request for court, but we cannot guarantee completion of requests received less than 3 business days from the court date. If one of the following special circumstances is documented in the court order, the requestor will be advised of the appropriate course of action: 1) If the court order is requesting a second opinion psychiatric evaluation, then the Service Manager will document the request and transfer the caller to Cenpatico Care Coordination for a referral to an in-network psychiatrist. 2) If the court order is requesting a second opinion psychiatric evaluation or medication review outside of the STAR Health network, the Service Manager will advise the caller that evaluations outside the STAR Health network are not a covered benefit even with court order. Psychiatric reevaluations under these circumstances are the responsibility of DFPS. - 5 -

Obtaining the PMUR Results Q: If I ve requested a formal PMUR report, how will I get a copy of the report? A: The Cenpatico Service Managers will send a copy of the completed formal PMUR report to the CPS Caseworker, Regional Nurse Consultant, Medical Administration, and DFPS Medical Director. In addition, the PMUR report will be posted to Health Passport within approximately 7 business days of completion. PMUR reports can be found in Health Passport under the Forms tab on the navigation panel of the left side of the screen, then behavioral health once the documents screen finishes loading. Q: If I speak to a Cenpatico Service Manager and my request does not result in a formal PMUR report, can I get documentation that the medication regimen was reviewed? A: Please notify the Cenpatico Service Manager that you need documentation that the child s medication regimen was reviewed, and provide your contact information. The Cenpatico Service Manager will send you a letter advising that the child s medication regimen was reviewed but did not meet criteria for a formal review within 3 business days. PMUR Determinations The PMUR report will contain a formal determination about the foster child s medication regimen. The possible determinations are as follows: Medication regimen within Parameters Medication regimen outside Parameters. Medication regimen reviewed and found to be within the standard of care Medication regimen outside Parameters, and there is opportunity to reduce polypharmacy Medication regimen is outside Parameters, and there is risk for or evidence of significant side effects Q: How can the PMUR determination be within Parameters when the medication prescribed does not appear in the DFPS Parameters? A: The DFPS Parameters clearly indicate that not all medications or doses which can be prescribed to treat childhood mental health disorders are included. Since the Parameters were published in 2013, new medications have been - 6 -

developed, and many medications have been recently approved for other uses, and younger age groups. The Parameters have been revised, but even the updated September 2013 Parameters will not contain all medications or doses which can be prescribed to treat childhood mental health disorders. Q: I have read the PMUR report, and I don t understand what outside Parameters but within the standard of care means? A: There are times when the child s diagnosis or combination of diagnoses may require the use of multiple medications or doses of medications which fall outside the dosing guidelines described in the current Parameters. This determination is made based on a review of the current accepted treatments, and the individual child s medical record, symptom severity, peer-peer contact, the prescriber s reasons for choosing the medications, and weighing the benefits versus risks. Q: If the determination made is outside Parameters, and there is opportunity to reduce polypharmacy should the extra medication be stopped? A: If this determination is made as a result of the PMUR process, Cenpatico encourages CPS staff, medical consenters, caregivers or other interested parties NOT to stop any medications unless directed by a physician. Quickly changing or stopping medication can have serious side consequences, and side effects more severe than just continuing the medications. It may take days to weeks to safely stop or change medications, and Cenpatico will work with the treating physician and will review cases with this determination on an ongoing basis to see if the medications have been reduced. Q: What happens when the determination is outside Parameters, and there is risk for or evidence of serious side effects? A: In these cases, the DFPS Medical Director is notified, so that specific actions can be planned. Again, Cenpatico emphasizes that any medication(s) should NOT be stopped unless directed by a physician. Cenpatico Service Management can assist in finding a new treating physician if necessary. - 7 -

Quality of Care Concerns Q: How does Cenpatico handle quality of care concerns identified through the PMUR process? A: Physicians who appear to consistently prescribe outside Parameters, and there is an opportunity to reduce polypharmacy or outside Parameters and there is risk for or evidence of significant side effects are referred to the Quality of Care review process. Additional records will be requested, and the cases reviewed in detail. If over-prescribing or dangerous prescribing is identified as a pervasive pattern, the cases and physician will be referred to the Credentialing Committee for further investigation, and action. Please note the results of Quality Improvement and Credentialing Committee investigations and actions are confidential and may not be released to or discussed with the public. Q: What response will I receive when I submit a QOC? A: You will receive an acknowledgement in writing within 5 business days and a thorough investigation of the concern will be conducted; however, results of the Quality Improvement and Credentialing Committee investigations and actions are confidential. The results may not be released to or discussed with the public, or the person filing the concern. All QOC issues are tracked and trended. Any practitioner showing a pattern or trend may be placed on corrective action and/or face disciplinary action up to and including termination if warranted. - 8 -